ACTIVE SUBSTANCE / INN

AMLODIPINE;VALSARTAN

Brand name(s): Copalia, Imprida, Amlodipine / Valsartan Mylan, Exforge, Dafiro
EMA LISTED
WITHDRAWN
AUTHORISED
Hypertension
ACTIVE SUBSTANCE
Amlodipine;Valsartan
REGULATORS
EMA
SPONSORS / MAH
Mylan Pharmaceuticals Limited, Novartis Europharm Ltd, Novartis Europharm Limited
TOTAL APPLICATIONS
5
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
DafiroNovartis Europharm LimitedAuthorised15/01/2007Hypertension
CopaliaNovartis Europharm LimitedAuthorised15/01/2007Hypertension
ExforgeNovartis Europharm LimitedAuthorised16/01/2007Hypertension
Amlodipine / Valsartan MylanMylan Pharmaceuticals LimitedAuthorised22/03/2016Hypertension
ImpridaNovartis Europharm LtdWithdrawn17/01/2007Hypertension

FULL INTELLIGENCE ON AMLODIPINE;VALSARTAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →